Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NER1006 versus sodium picosulfate + magnesium salts for bowel cleansing before colonoscopy
NL-OMON41935Phase 3Active, not recruiting
- Sponsor
- Norgine
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of polyethylene glycol plus ascorbate and sodium picosulfate + magnesium salts (2 arms), sponsored by Norgine. Primary endpoints: Overall bowel cleansing success rate and Excellent plus Good cleansing rate in the ascending colon. Started Mar 2015; status: active, not recruiting.
02
Drugs
polyethylene glycol plus ascorbatesodium picosulfate + magnesium salts
Beyond the preview
Go deeper on NL-OMON41935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41935.